Here's Why TherapeuticsMD Stock Bounded Higher on Wednesday
Shares of TherapeuticsMD (NASDAQ: TXMD), a biopharmaceutical company focused on women's health, are rising in response to the company's latest presentation. Investors pleased to see the Imvexxy launch exceeding expectations drove the stock 14.6% higher on Wednesday.
TherapeuticsMD had a hard time convincing investors that Imvexxy, an estrogen insert for the treatment of menopause-related dyspareunia, would outperform decades-old treatment options that use the same hormone. The company's second-quarter earnings report, though, suggested Imvexxy sales were accelerating. The pharma stock popped today because August sales figures contained in today's investor presentation further suggest Imvexxy sales are taking flight.
Image source: Getty Images.
Source Fool.com
